PLAU and metabolic dysfunction-associated steatohepatitis: The MUP-uPA mice placed on a HFD exhibited significantly upregulated liver injury markers of NASH, including ER-stress, fibrosis and inflammation at 24 weeks (Nakagawa et al., 2014; Lebeaupin et al., 2018).